Skip to main content
SpringerLink
Log in

The radiation treatment of medulloblastoma

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Following the introduction of CS-RT the survival rate for this malignant tumour rose from zero to approximately 50%. It appears that the major advances over the last twenty years associated with the introduction of CT/MRI, adequate staging, total resection, adjuvant therapy and improved radiation technique has only added 10–20% to the survival rate making it extremely difficult to evaluate the impact of these advances. While radiation treatment is currently omitted or delayed under the age of 36 months, due to enhanced neurocognitive toxicity, and replaced by maintained systemic therapy, the early encouraging results must stand the test of time in order to become standard practice. The treatment of a child with medulloblastoma with radiation treatment remains the corner stone of treatment while additional novel therapies are being developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Paterson E: Treatment of cerebral tumours in children by irradiation. J Faculty of Radiologists 4: 175–179, 1953

    Google Scholar 

  2. Jenkin RDT: Medulloblastoma in childhood, radiation therapy. Canadian Med Assoc J 100: 51–53, 1969

    Google Scholar 

  3. Van Dyk J, Jenkin RDT, Leung PMK, Cunningham JR: Medulloblastoma: treatment technique and radiation dosimetry. Int J Radiation Oncology. Biol Phys 2: 993–1005, 1977

    Google Scholar 

  4. Carrie C, Alapetite C, Mere P, Aimard L, Pons A, Kollodie H, Seng S, Lagrange JL, Pontvert D, Pignon T, Lacroze M, Ginestet C, Bernard JL: Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: The contribution of radiotherapy technique to relapse. Radiotherapy & Oncology 24: 77–81, 1992

    Google Scholar 

  5. Dunbar SF, Barnes PD, Tarbell NJ: Radiologic determination of the caudal border of the spinal field in cranial spinal irradiation. Int J Radiation Oncology Biol Phys 26: 669–673, 1993

    Google Scholar 

  6. Halperin EC: Concerning the inferior portion of the spinal radiotherapy field for malignancies that disseminate via the cerebral spinal fluid. Int J Radiation Oncology Biol Phys 26: 357–362, 1993

    Google Scholar 

  7. Jereb B, Sundaresan N, Herten B, Reid A, Galicich J: Supratentorial recurrences in medulloblastoma. Cancer 47: 806–809, 1981

    Google Scholar 

  8. Uozumi A, Yamaura A, Makino H, Miyoshi T, Arimizu N: A newly designed radiation port for medulloblastoma to prevent metastases to the Cribriform Plate Region. Child's Nerv Syst 6: 451–455, 1990

    Google Scholar 

  9. Jereb B, Krishnaswami S, Reid A, Allen J: Radiation for medulloblastoma adjusted to prevent recurrence to Cribriform Plate Region. Cancer 54: 602–604, 1984

    Google Scholar 

  10. Jenkin D, Goddard K, Armstrong D, Becker L, Berry M, Chan H, Doherty M, Greenberg M, Hendrick B, Hoffman H, Humphreys R, Sonley M, Weitzman S, Zipursky A: Posterior fossa medulloblastoma in childhood: Treatment results and a proposal for a new staging system. Int J Radiation Oncology Biol Phys 19: 265–274, 1990

    Google Scholar 

  11. Muller-Runkel R, Vijayakumar S: Spinal axis irradiation with electrons: Measurements of attenuation by the spinal processes. Med Phys 13: 539–543, 1986

    Google Scholar 

  12. Vijyakumar S, Muller-Runkel R: Medulloblastoma therapy using electron beams. Radiology 157: 541–542, 1985

    Google Scholar 

  13. Dewit L, Van Dam J, Rijnders A, Van De Velde G, Kian Ang K, Van Der Schueren E: Int J Radiation Oncology Biol Phys 10: 231–241, 1984

    Google Scholar 

  14. Gaspar LE, Dawson DJ, Tilley-Gulliford SA, Banerjee P: Medulloblastoma: Long term follow-up of patients treated with electron irradiation of the spinal field. Oncology 180: 867–870, 1991

    Google Scholar 

  15. Silverman CL, Simpson JR: Cerebellar medulloblastoma: The importance of posterior fossa, dose to survival and patterns of failure. Int J Radiation Oncology Biol Phys 8: 1869–1876, 1982

    Google Scholar 

  16. Hughes EN, Shillito J, Sallon SE, Loeffler JS, Cassady JR, Tarbell NJ: Medulloblastoma at the joint centre for radiation therapy between 1968 and 1984. Cancer 61: 1992–1998, 1988

    Google Scholar 

  17. Evans AE, Jenkin RDT, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL, Hammond GD: The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, Vincristine & Prednisone. J Neurosurg 72: 572–582, 1990

    Google Scholar 

  18. Tait DM, Thornton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P: Ajuvant chemotherapy for medulloblastoma: The first multicentre controlled trial of the international society of paediatric oncology (SIOP I). Eur J Cancer 26: 464–469, 1990

    Google Scholar 

  19. Berry MP, Jenkin RDT, Keen CW, Nair BD, Simpson WJ: Radiation of medulloblastoma. A twenty-one year review. J Neurosurg 55: 43–51, 1981

    Google Scholar 

  20. Wara WM, Le QX, Sneed PK, Larsan DA, Prados MD, Levin VA, Edwards MSB, Wiel M: Int J Radiation Oncology Biol Phys 30: 551–556, 1994

    Google Scholar 

  21. Deutch M, Thomas P, Boyett J, Krischer JP, Finlay J, Kun L, Hammond D, Vietti T: Low stage medulloblastoma: A childrens cancer study group (CCSG) and paediatric oncology group (POG) randomized study of standard vs reduced neuraxis irradiation. Proc Ann Meet Am Soc Clin Oncol 10: A363, 1991

    Google Scholar 

  22. Neidhardt MK, Bailey CC: Prospective randomized cooperative medulloblastoma trial (MED84) of the International Society of Paediatric Oncology (SIOP) (German) Society of Paediatric Oncology (GPO). Childs Nerv Syst 3: 70–73, 1987

    Google Scholar 

  23. Gentet JC, Bouffet E, Doz F, Tron P, Roche H, Thyss A, Plantaz D, Stephan JL, Mottolese C, Ponvert D, Carrie C, Raybaud C, Brunat-Mentigny M, Choux M, Philip T, Zucker JM, Bernard JL: Pre-irradiation chemotherapy including ‘Eight Drugs in One Day’ regimens and high dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study. J Neurosurg 82: 608–614, 1995

    Google Scholar 

  24. Tomita T, McLone DG: Medulloblastoma in childhood: Results of radical resection and low-dose neuraxis radiation therapy. J Neurosurg 64: 230–242, 1986

    Google Scholar 

  25. Brand WN, Schneider PA, Tokars RP: Long term results of a pilot study of low dose cranial-spinal irradiation for cerebellar medulloblastoma. Int J Radiation Oncology Biol Phys 13: 1641–1645, 1987

    Google Scholar 

  26. Goldwein JW, Radcliffe J, Packer RJ, Sutton LN, Lange B, Rorke LB, A'Angio G: Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than five years with primitive neuroectodermal tumours. Cancer 71: 2647–2652, 1993

    Google Scholar 

  27. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, Rorke LB, Evans AE, Schut L: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 433–440, 1991

    Google Scholar 

  28. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K, Reaman G, Cohen BH, Bruce DA, Rorke LB, Malloy P, Ryan J, LaFond D, Evans AE, Schut L: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU and vincristine chemotherapy. J Neurosurg 81: 690–698, 1994

    Google Scholar 

  29. Halberg FE, Wara W, Fippin LF, Edwards MSB, Levin VA, Davis RL, Prados MB, Wilson CB: Low-dose craniospinal radiation therapy for DV medulloblastoma. Int J Radiation Oncology Biol Phys 651–654, 1991

  30. Gnekow AK, Bailey C, Machaelis J, Wellek S, Kleihues P: SIOP/GPO medulloblastoma trial. Med'84: Med Ped Oncol 18: 426 (Abstract 224), 1990

    Google Scholar 

  31. Bouffet E, Bernard JL, Frappaz D, Gentet JC, Roche H, Tron P, Carrie C, Raybaud C, Joannard A, Lapras C, Choux N, Carton M, Aimard L, Philip T, Brunat-Mentingy M: M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided. Int J Radiation Oncology Biol Phys 24: 79–85, 1992

    Google Scholar 

  32. Krischer JP, Ragaba H, Kun L, Kim TH, Laurent JP, Boyett JM, Cornell CJ, Link M, Luthy A, Camitta B: Nitrogen mustard, vincristine, procarbazine and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A paediatric oncology group study. J Neurosurg 74: 905–909, 1991

    Google Scholar 

  33. Zeltzer P, Boyett J, Finlay J, Albright L, Wisoff J, Geyer R, McGuire P, Allen J, Rorke L, Stanley P, Stehbens J, Stevens K, Shurin S, Milstein J, Packer R, Bleyer A: Prognostic factors for survival in high risk primitive neuroectodermal tumours (PNET) in children: report from the childrens cancer group. Proceedings ASCO 12: 415, Abstract 1425, 1993

    Google Scholar 

  34. Attard-Montalto S, Plowman N, Breatnach F, Saha V, Eden OB: Is there a danger in delaying the radiotherapy in childhood medulloblastoma? The British Journal of Radiology 66: 807–813, 1993

    Google Scholar 

  35. Scolfield DE, Yunis EJ, Geyer JR, Albright AL, Berger MS, Taylor SR: DNA content and other prognostic factors in childhood medulloblastoma. Cancer 69: 1307–1314, 1992

    Google Scholar 

  36. Garson JA, Pemberton LF, Sheppard PW, Varndelli N, Coakham HB, Kemshead JT: N-myc gene expression and oncoprotein characterization in medulloblastoma. Br J Cancer 59: 889–894, 1989

    Google Scholar 

  37. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD: Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Research 50: 2347–2350, 1990

    Google Scholar 

  38. Zerbini C, Gelber RD, Weinberg D, Sallan S, Barnes P, Kupsky W, Scott RM, Tarbell NJ: Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 11: 616–622, 1993

    Google Scholar 

  39. Tait DM, Eeles RA, Carter R, Ashley S, Ormerod MG: Ploidy and proliferative index in medulloblastoma: Useful prognostic factors? Eur J Cancer 29A: 1383–1387, 1993

    Google Scholar 

  40. Gilbertson RJ, Jarose B, Perry RH, Pearson ADJ: Prognostic factors in medulloblastoma. Lancet 480,1992

  41. Roberts RO, Lynch CF, Jones MP, Hart MN: Medulloblastoma: A population based study of 532 cases. J Neuropath Exper Neurology 50: 134–144, 1991

    Google Scholar 

  42. Stiller CA, Lennox EL: Childhood medulloblastoma in Britain 1971–77: Analysis of treatment and survival. Br J Cancer 48: 835–841, 1983

    Google Scholar 

  43. Bourne JP, Geyer R, Berger M, Griffin B, Milstein J: The prognostic significance of post-operative residual contrast enhancement on CT scan in paediatric patients with medulloblastoma. J Neuro-Oncology 14: 263–270, 1992

    Google Scholar 

  44. Duffner PK, Horowitz ME, Jeffrey MD, Krischer P, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Seidel FG, Kun LE: Post-operative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumours. N Engl J Med 328: 1725–1731, 1993

    Google Scholar 

  45. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL, Ayers GD, Shurin SB, Stevens KR, Bleyers WA: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the childrens cancer group. J Clin Oncol 12: 1607–1615, 1994

    Google Scholar 

  46. Gajjar A, Mulhern RK, Heideman RL, Sanford RA, Douglas EC, Kovnar EH, Langston JA, Jenkins JJ, Kun LE: Medulloblastoma in very young children: outcome of definitive craniospinal irradiation folllowing incomplete response to chemotherapy. J Clin Oncology 12: 1212–1216, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation and Pediatrics, Toronto-Sunnybrook Regional Cancer Centre and Hospital for Sick Children, Toronto, Canada

    Derek Jenkin

Authors
  1. Derek Jenkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jenkin, D. The radiation treatment of medulloblastoma. J Neuro-Oncol 29, 45–54 (1996). https://doi.org/10.1007/BF00165517

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165517

Key words

Search

Navigation